M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
Thermo Fisher Scientific is nearing a deal for Solventum’s purification and filtration business, according to people familiar ...
7d
Dealbreaker on MSNThermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz SegmentThermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
8d
GlobalData on MSNThermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unitGlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...
The deal should allow Thermo to enter the filtration category in bioprocessing, where peers Danaher and Repligen are more ...
Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results